Your browser doesn't support javascript.
loading
Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
Bayraktar, Abdulahad; Li, Xiangyu; Kim, Woonghee; Zhang, Cheng; Turkez, Hasan; Shoaie, Saeed; Mardinoglu, Adil.
Afiliação
  • Bayraktar A; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, SE1 9RT, UK.
  • Li X; Bash Biotech Inc, 600 West Broadway, Suite 700, San Diego, CA, 92101, USA.
  • Kim W; Science for Life Laboratory, KTH-Royal Institute of Technology, SE-17121, Stockholm, Sweden.
  • Zhang C; Science for Life Laboratory, KTH-Royal Institute of Technology, SE-17121, Stockholm, Sweden.
  • Turkez H; Science for Life Laboratory, KTH-Royal Institute of Technology, SE-17121, Stockholm, Sweden.
  • Shoaie S; Department of Medical Biology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
  • Mardinoglu A; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, SE1 9RT, UK.
J Transl Med ; 21(1): 332, 2023 05 20.
Article em En | MEDLINE | ID: mdl-37210557
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article